Quick Answer
Fuse Medical, Inc. reported Diluted EPS of $0.04 per share for fiscal year 2022.
Fuse Medical, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2022 | $0.04 | +300.0% |
| 2021 | -$0.02 | +0.0% |
| 2020 | -$0.02 | +60.0% |
| 2019 | -$0.05 | -200.0% |
| 2018 | $0.05 | +25.0% |
| 2017 | $0.04 | -87.9% |
| 2016 | $0.33 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | $0.00 | +100.0% | +100.0% |
| March 31, 2022 | -$0.01 | — | +0.0% |
| September 30, 2021 | -$0.01 | — | — |
| September 30, 2020 | $0.00 | +100.0% | +100.0% |
| September 30, 2019 | -$0.06 | — | — |
| September 30, 2018 | $0.00 | -100.0% | +100.0% |
| June 30, 2018 | -$0.04 | -200.0% | -233.3% |
| September 30, 2017 | $0.03 | — | -25.0% |
- Fuse Medical, Inc. showed an increase of +300.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2016–2022 period, Fuse Medical, Inc.’s diluted eps has declined by 87.9% (from $0.33 per share to $0.04 per share).
- The most recent figure is from Fuse Medical, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on April 14, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: